🔎 Trials Near Me

Dachaigh › Galar Crohn › Missouri › St. Louis

Sgrùdaidhean clionaigeach Galar Crohn ann an St. Louis, MO

Tha 19 sgrùdaidhean airson Galar Crohn a’ lorg phàirtichean aig làraichean ann agus timcheall air St. Louis (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

A’ fastadhÌre 2
  • Specialists In Gastroenterology /ID# 283939, St Louis
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07697456

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

A’ fastadhÌre 1
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • agus 1 a bharrachd
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT03816345

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

A’ fastadhÌre 3
  • Washington University School of Medicine ( Site 5058), St Louis
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06430801

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

A’ fastadhÌre 4
  • SSM Health Medical Group, Bridgeton · 15 mìle air falbh
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

A’ fastadhÌre 2
  • Washington University /ID# 266938, St Louis
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06548542

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

A’ fastadhÌre 3
  • Washington University School of Medicine, St Louis
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

A’ fastadhÌre 3
  • Washington University School of Medicine-Site Number: 8400075, St Louis
  • Gateway Gastroenterology-Site Number: 8400097, St Louis
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

A’ fastadhÌre 3
  • Gateway Gastroenterology-Site Number: 8400097, St Louis
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07184944

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

A’ fastadhÌre 3
  • Washington University School of Medicine, St Louis
Aoisean 2 gu 19 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT04844606

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

A’ fastadhÌre 2
  • KAD Clinical Research, St Louis
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07483099

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

A’ fastadhÌre 2
  • SSM Health DePaul Hospital- St. Louis, Bridgeton · 15 mìle air falbh
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06226883

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

A’ fastadhÌre 2
  • KAD Clinical Research, St Louis
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07483073

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

A’ fastadhÌre 4
  • Washington University School of Medicine, St Louis
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06045754

DB-3Q for the Treatment of Medically Refractory Crohn's Disease

A’ fastadhÌre 2
  • Washington University, St. Louis, St Louis
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT07625293

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

A’ fastadhÌre 2
  • Washington University School of Medicine, St Louis
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 5 Ògmh 2026 · NCT06976853

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

A’ fastadhÌre 2
  • Investigational Site Number: 8400013, St Louis
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 27 Màrt 2026 · NCT06958536

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

A’ fastadhÌre 2
  • Mirador Therapeutics Selected Site, Bridgeton · 15 mìle air falbh
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 12 Màrt 2026 · NCT07113522

Treatment of Moderate to Severe Refractory Crohn's Disease

A’ fastadhÌre 1/2
  • Washington University in St. Louis, St Louis
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 10 Dùbh 2025 · NCT06721962

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy

A’ fastadhSgrùdadh amharc
  • Washington University in St Louis School of Medicine, St Louis
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Samh 2025 · NCT06670638

Sgrùdaidhean Galar Crohn ann am bailtean eile

Sgrùdaidhean eile ann an St. Louis

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.